Evidence map›Paper›PMID 36942148›Full record

ArticleThe Pan African medical journal2022

[Primary malignant salivary gland-type tumors of the lung: clinico-pathological study of 10 cases].

Ahlem Bchir, Slim Ben Ahmed, Moncef Mokni

Open access · goldFull text readCase ReportsEnglish Abstract
In one paragraph

Article in The Pan African medical journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ahlem BchirLaboratoire d´Anatomie et Cytologie Pathologique, Centre Hospitalier Universitaire Farhat Hached de Sousse, Sousse, Tunisie.
Slim Ben AhmedFaculté de Médecine Ibn Jazzar, Sousse, Tunisie.
Moncef MokniLaboratoire d´Anatomie et Cytologie Pathologique, Centre Hospitalier Universitaire Farhat Hached de Sousse, Sousse, Tunisie.
Hôpital Farhat Hached · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary pulmonary salivary gland-type tumors are rare and characterized by a specific clinico-pathological manifestation. They are proximal tumors affecting young subjects and not associated with smoking. For optimal management, it is important to distinguish them from other bronchopulmonary tumors, with which they don´t share either biology or treatment and outcome. We conducted a retrospective study, including all primary malignant salivary gland-type tumors of the lung, over a period of 32 years, from January 1987 to December 2019. We collected data from the medical records of 10 patients: 5 men and 5 women (sex ratio 1). The average age of our patients was 47.4 years. In all cases radiological examinations showed proximally located nodular tumor ranging in size from 1 to 5.8 cm. Histological examination objectified mucoepidermoid carcinoma (6 out of 10 cases). All patients had localized or locally advanced tumors, with the exception of one case of metastatic mucoepidermoid carcinoma. Pulmonary salivary gland-type tumors correspond to a heterogeneous group of tumours. They are not very aggressive but are associated with a high frequency of recurrences and late metastases, requiring long-term monitoring.

Indexed as

Adenoma, PleomorphicCarcinomaCarcinoma, Adenoid CysticCarcinoma, MucoepidermoidLung NeoplasmsSalivary Gland NeoplasmsFemaleHumansMaleMiddle AgedRetrospective StudiesSalivary Glandsadenoid cystic carcinomalungmucoepidermoid carcinomaprognosisSalivary gland-type tumor

Identifiers

PMID36942148
PMCPMC10024559
OpenAlexW4312303203

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read21
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.